Global Gene Therapy for CNS Disorders Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Gene Therapy for CNS Disorders market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Gene Therapy for CNS Disorders market are covered in Chapter 9:
Roche (Spark Therapeutics)
Voyager Therapeutics
Novartis AG
Pfizer Inc.
Biogen
bluebird bio, Inc.
In Chapter 5 and Chapter 7.3, based on types, the Gene Therapy for CNS Disorders market from 2017 to 2027 is primarily split into:
AAV
Adenovirus
In Chapter 6 and Chapter 7.4, based on applications, the Gene Therapy for CNS Disorders market from 2017 to 2027 covers:
SMA
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Gene Therapy for CNS Disorders market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Gene Therapy for CNS Disorders Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 GENE THERAPY FOR CNS DISORDERS MARKET OVERVIEW
1.1 Product Overview and Scope of Gene Therapy for CNS Disorders Market
1.2 Gene Therapy for CNS Disorders Market Segment by Type
1.2.1 Global Gene Therapy for CNS Disorders Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Gene Therapy for CNS Disorders Market Segment by Application
1.3.1 Gene Therapy for CNS Disorders Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Gene Therapy for CNS Disorders Market, Region Wise (2017-2027)
1.4.1 Global Gene Therapy for CNS Disorders Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Gene Therapy for CNS Disorders Market Status and Prospect (2017-2027)
1.4.3 Europe Gene Therapy for CNS Disorders Market Status and Prospect (2017-2027)
1.4.4 China Gene Therapy for CNS Disorders Market Status and Prospect (2017-2027)
1.4.5 Japan Gene Therapy for CNS Disorders Market Status and Prospect (2017-2027)
1.4.6 India Gene Therapy for CNS Disorders Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Gene Therapy for CNS Disorders Market Status and Prospect (2017-2027)
1.4.8 Latin America Gene Therapy for CNS Disorders Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Gene Therapy for CNS Disorders Market Status and Prospect (2017-2027)
1.5 Global Market Size of Gene Therapy for CNS Disorders (2017-2027)
1.5.1 Global Gene Therapy for CNS Disorders Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Gene Therapy for CNS Disorders Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Gene Therapy for CNS Disorders Market
2 INDUSTRY OUTLOOK
2.1 Gene Therapy for CNS Disorders Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Gene Therapy for CNS Disorders Market Drivers Analysis
2.4 Gene Therapy for CNS Disorders Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Gene Therapy for CNS Disorders Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Gene Therapy for CNS Disorders Industry Development
3 GLOBAL GENE THERAPY FOR CNS DISORDERS MARKET LANDSCAPE BY PLAYER
3.1 Global Gene Therapy for CNS Disorders Sales Volume and Share by Player (2017-2022)
3.2 Global Gene Therapy for CNS Disorders Revenue and Market Share by Player (2017-2022)
3.3 Global Gene Therapy for CNS Disorders Average Price by Player (2017-2022)
3.4 Global Gene Therapy for CNS Disorders Gross Margin by Player (2017-2022)
3.5 Gene Therapy for CNS Disorders Market Competitive Situation and Trends
3.5.1 Gene Therapy for CNS Disorders Market Concentration Rate
3.5.2 Gene Therapy for CNS Disorders Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL GENE THERAPY FOR CNS DISORDERS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Gene Therapy for CNS Disorders Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Gene Therapy for CNS Disorders Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Gene Therapy for CNS Disorders Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Gene Therapy for CNS Disorders Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Gene Therapy for CNS Disorders Market Under COVID-19
4.5 Europe Gene Therapy for CNS Disorders Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Gene Therapy for CNS Disorders Market Under COVID-19
4.6 China Gene Therapy for CNS Disorders Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Gene Therapy for CNS Disorders Market Under COVID-19
4.7 Japan Gene Therapy for CNS Disorders Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Gene Therapy for CNS Disorders Market Under COVID-19
4.8 India Gene Therapy for CNS Disorders Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Gene Therapy for CNS Disorders Market Under COVID-19
4.9 Southeast Asia Gene Therapy for CNS Disorders Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Gene Therapy for CNS Disorders Market Under COVID-19
4.10 Latin America Gene Therapy for CNS Disorders Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Gene Therapy for CNS Disorders Market Under COVID-19
4.11 Middle East and Africa Gene Therapy for CNS Disorders Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Gene Therapy for CNS Disorders Market Under COVID-19
5 GLOBAL GENE THERAPY FOR CNS DISORDERS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Gene Therapy for CNS Disorders Sales Volume and Market Share by Type (2017-2022)
5.2 Global Gene Therapy for CNS Disorders Revenue and Market Share by Type (2017-2022)
5.3 Global Gene Therapy for CNS Disorders Price by Type (2017-2022)
5.4 Global Gene Therapy for CNS Disorders Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Gene Therapy for CNS Disorders Sales Volume, Revenue and Growth Rate of AAV (2017-2022)
5.4.2 Global Gene Therapy for CNS Disorders Sales Volume, Revenue and Growth Rate of Adenovirus (2017-2022)
6 GLOBAL GENE THERAPY FOR CNS DISORDERS MARKET ANALYSIS BY APPLICATION
6.1 Global Gene Therapy for CNS Disorders Consumption and Market Share by Application (2017-2022)
6.2 Global Gene Therapy for CNS Disorders Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Gene Therapy for CNS Disorders Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Gene Therapy for CNS Disorders Consumption and Growth Rate of SMA (2017-2022)
6.3.2 Global Gene Therapy for CNS Disorders Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL GENE THERAPY FOR CNS DISORDERS MARKET FORECAST (2022-2027)
7.1 Global Gene Therapy for CNS Disorders Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Gene Therapy for CNS Disorders Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Gene Therapy for CNS Disorders Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Gene Therapy for CNS Disorders Price and Trend Forecast (2022-2027)
7.2 Global Gene Therapy for CNS Disorders Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Gene Therapy for CNS Disorders Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Gene Therapy for CNS Disorders Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Gene Therapy for CNS Disorders Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Gene Therapy for CNS Disorders Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Gene Therapy for CNS Disorders Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Gene Therapy for CNS Disorders Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Gene Therapy for CNS Disorders Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Gene Therapy for CNS Disorders Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Gene Therapy for CNS Disorders Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Gene Therapy for CNS Disorders Revenue and Growth Rate of AAV (2022-2027)
7.3.2 Global Gene Therapy for CNS Disorders Revenue and Growth Rate of Adenovirus (2022-2027)
7.4 Global Gene Therapy for CNS Disorders Consumption Forecast by Application (2022-2027)
7.4.1 Global Gene Therapy for CNS Disorders Consumption Value and Growth Rate of SMA(2022-2027)
7.4.2 Global Gene Therapy for CNS Disorders Consumption Value and Growth Rate of Others(2022-2027)
7.5 Gene Therapy for CNS Disorders Market Forecast Under COVID-19
8 GENE THERAPY FOR CNS DISORDERS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Gene Therapy for CNS Disorders Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Gene Therapy for CNS Disorders Analysis
8.6 Major Downstream Buyers of Gene Therapy for CNS Disorders Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Gene Therapy for CNS Disorders Industry
9 PLAYERS PROFILES
9.1 Roche (Spark Therapeutics)
9.1.1 Roche (Spark Therapeutics) Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Gene Therapy for CNS Disorders Product Profiles, Application and Specification
9.1.3 Roche (Spark Therapeutics) Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Voyager Therapeutics
9.2.1 Voyager Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Gene Therapy for CNS Disorders Product Profiles, Application and Specification
9.2.3 Voyager Therapeutics Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Novartis AG
9.3.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Gene Therapy for CNS Disorders Product Profiles, Application and Specification
9.3.3 Novartis AG Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Pfizer Inc.
9.4.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Gene Therapy for CNS Disorders Product Profiles, Application and Specification
9.4.3 Pfizer Inc. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Biogen
9.5.1 Biogen Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Gene Therapy for CNS Disorders Product Profiles, Application and Specification
9.5.3 Biogen Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 bluebird bio, Inc.
9.6.1 bluebird bio, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Gene Therapy for CNS Disorders Product Profiles, Application and Specification
9.6.3 bluebird bio, Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Gene Therapy for CNS Disorders Market
1.2 Gene Therapy for CNS Disorders Market Segment by Type
1.2.1 Global Gene Therapy for CNS Disorders Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Gene Therapy for CNS Disorders Market Segment by Application
1.3.1 Gene Therapy for CNS Disorders Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Gene Therapy for CNS Disorders Market, Region Wise (2017-2027)
1.4.1 Global Gene Therapy for CNS Disorders Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Gene Therapy for CNS Disorders Market Status and Prospect (2017-2027)
1.4.3 Europe Gene Therapy for CNS Disorders Market Status and Prospect (2017-2027)
1.4.4 China Gene Therapy for CNS Disorders Market Status and Prospect (2017-2027)
1.4.5 Japan Gene Therapy for CNS Disorders Market Status and Prospect (2017-2027)
1.4.6 India Gene Therapy for CNS Disorders Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Gene Therapy for CNS Disorders Market Status and Prospect (2017-2027)
1.4.8 Latin America Gene Therapy for CNS Disorders Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Gene Therapy for CNS Disorders Market Status and Prospect (2017-2027)
1.5 Global Market Size of Gene Therapy for CNS Disorders (2017-2027)
1.5.1 Global Gene Therapy for CNS Disorders Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Gene Therapy for CNS Disorders Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Gene Therapy for CNS Disorders Market
2 INDUSTRY OUTLOOK
2.1 Gene Therapy for CNS Disorders Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Gene Therapy for CNS Disorders Market Drivers Analysis
2.4 Gene Therapy for CNS Disorders Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Gene Therapy for CNS Disorders Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Gene Therapy for CNS Disorders Industry Development
3 GLOBAL GENE THERAPY FOR CNS DISORDERS MARKET LANDSCAPE BY PLAYER
3.1 Global Gene Therapy for CNS Disorders Sales Volume and Share by Player (2017-2022)
3.2 Global Gene Therapy for CNS Disorders Revenue and Market Share by Player (2017-2022)
3.3 Global Gene Therapy for CNS Disorders Average Price by Player (2017-2022)
3.4 Global Gene Therapy for CNS Disorders Gross Margin by Player (2017-2022)
3.5 Gene Therapy for CNS Disorders Market Competitive Situation and Trends
3.5.1 Gene Therapy for CNS Disorders Market Concentration Rate
3.5.2 Gene Therapy for CNS Disorders Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL GENE THERAPY FOR CNS DISORDERS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Gene Therapy for CNS Disorders Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Gene Therapy for CNS Disorders Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Gene Therapy for CNS Disorders Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Gene Therapy for CNS Disorders Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Gene Therapy for CNS Disorders Market Under COVID-19
4.5 Europe Gene Therapy for CNS Disorders Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Gene Therapy for CNS Disorders Market Under COVID-19
4.6 China Gene Therapy for CNS Disorders Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Gene Therapy for CNS Disorders Market Under COVID-19
4.7 Japan Gene Therapy for CNS Disorders Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Gene Therapy for CNS Disorders Market Under COVID-19
4.8 India Gene Therapy for CNS Disorders Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Gene Therapy for CNS Disorders Market Under COVID-19
4.9 Southeast Asia Gene Therapy for CNS Disorders Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Gene Therapy for CNS Disorders Market Under COVID-19
4.10 Latin America Gene Therapy for CNS Disorders Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Gene Therapy for CNS Disorders Market Under COVID-19
4.11 Middle East and Africa Gene Therapy for CNS Disorders Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Gene Therapy for CNS Disorders Market Under COVID-19
5 GLOBAL GENE THERAPY FOR CNS DISORDERS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Gene Therapy for CNS Disorders Sales Volume and Market Share by Type (2017-2022)
5.2 Global Gene Therapy for CNS Disorders Revenue and Market Share by Type (2017-2022)
5.3 Global Gene Therapy for CNS Disorders Price by Type (2017-2022)
5.4 Global Gene Therapy for CNS Disorders Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Gene Therapy for CNS Disorders Sales Volume, Revenue and Growth Rate of AAV (2017-2022)
5.4.2 Global Gene Therapy for CNS Disorders Sales Volume, Revenue and Growth Rate of Adenovirus (2017-2022)
6 GLOBAL GENE THERAPY FOR CNS DISORDERS MARKET ANALYSIS BY APPLICATION
6.1 Global Gene Therapy for CNS Disorders Consumption and Market Share by Application (2017-2022)
6.2 Global Gene Therapy for CNS Disorders Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Gene Therapy for CNS Disorders Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Gene Therapy for CNS Disorders Consumption and Growth Rate of SMA (2017-2022)
6.3.2 Global Gene Therapy for CNS Disorders Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL GENE THERAPY FOR CNS DISORDERS MARKET FORECAST (2022-2027)
7.1 Global Gene Therapy for CNS Disorders Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Gene Therapy for CNS Disorders Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Gene Therapy for CNS Disorders Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Gene Therapy for CNS Disorders Price and Trend Forecast (2022-2027)
7.2 Global Gene Therapy for CNS Disorders Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Gene Therapy for CNS Disorders Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Gene Therapy for CNS Disorders Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Gene Therapy for CNS Disorders Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Gene Therapy for CNS Disorders Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Gene Therapy for CNS Disorders Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Gene Therapy for CNS Disorders Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Gene Therapy for CNS Disorders Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Gene Therapy for CNS Disorders Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Gene Therapy for CNS Disorders Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Gene Therapy for CNS Disorders Revenue and Growth Rate of AAV (2022-2027)
7.3.2 Global Gene Therapy for CNS Disorders Revenue and Growth Rate of Adenovirus (2022-2027)
7.4 Global Gene Therapy for CNS Disorders Consumption Forecast by Application (2022-2027)
7.4.1 Global Gene Therapy for CNS Disorders Consumption Value and Growth Rate of SMA(2022-2027)
7.4.2 Global Gene Therapy for CNS Disorders Consumption Value and Growth Rate of Others(2022-2027)
7.5 Gene Therapy for CNS Disorders Market Forecast Under COVID-19
8 GENE THERAPY FOR CNS DISORDERS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Gene Therapy for CNS Disorders Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Gene Therapy for CNS Disorders Analysis
8.6 Major Downstream Buyers of Gene Therapy for CNS Disorders Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Gene Therapy for CNS Disorders Industry
9 PLAYERS PROFILES
9.1 Roche (Spark Therapeutics)
9.1.1 Roche (Spark Therapeutics) Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Gene Therapy for CNS Disorders Product Profiles, Application and Specification
9.1.3 Roche (Spark Therapeutics) Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Voyager Therapeutics
9.2.1 Voyager Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Gene Therapy for CNS Disorders Product Profiles, Application and Specification
9.2.3 Voyager Therapeutics Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Novartis AG
9.3.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Gene Therapy for CNS Disorders Product Profiles, Application and Specification
9.3.3 Novartis AG Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Pfizer Inc.
9.4.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Gene Therapy for CNS Disorders Product Profiles, Application and Specification
9.4.3 Pfizer Inc. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Biogen
9.5.1 Biogen Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Gene Therapy for CNS Disorders Product Profiles, Application and Specification
9.5.3 Biogen Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 bluebird bio, Inc.
9.6.1 bluebird bio, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Gene Therapy for CNS Disorders Product Profiles, Application and Specification
9.6.3 bluebird bio, Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Gene Therapy for CNS Disorders Product Picture
Table Global Gene Therapy for CNS Disorders Market Sales Volume and CAGR (%) Comparison by Type
Table Gene Therapy for CNS Disorders Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Gene Therapy for CNS Disorders Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Gene Therapy for CNS Disorders Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Gene Therapy for CNS Disorders Industry Development
Table Global Gene Therapy for CNS Disorders Sales Volume by Player (2017-2022)
Table Global Gene Therapy for CNS Disorders Sales Volume Share by Player (2017-2022)
Figure Global Gene Therapy for CNS Disorders Sales Volume Share by Player in 2021
Table Gene Therapy for CNS Disorders Revenue (Million USD) by Player (2017-2022)
Table Gene Therapy for CNS Disorders Revenue Market Share by Player (2017-2022)
Table Gene Therapy for CNS Disorders Price by Player (2017-2022)
Table Gene Therapy for CNS Disorders Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Gene Therapy for CNS Disorders Sales Volume, Region Wise (2017-2022)
Table Global Gene Therapy for CNS Disorders Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Gene Therapy for CNS Disorders Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Gene Therapy for CNS Disorders Sales Volume Market Share, Region Wise in 2021
Table Global Gene Therapy for CNS Disorders Revenue (Million USD), Region Wise (2017-2022)
Table Global Gene Therapy for CNS Disorders Revenue Market Share, Region Wise (2017-2022)
Figure Global Gene Therapy for CNS Disorders Revenue Market Share, Region Wise (2017-2022)
Figure Global Gene Therapy for CNS Disorders Revenue Market Share, Region Wise in 2021
Table Global Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Gene Therapy for CNS Disorders Sales Volume by Type (2017-2022)
Table Global Gene Therapy for CNS Disorders Sales Volume Market Share by Type (2017-2022)
Figure Global Gene Therapy for CNS Disorders Sales Volume Market Share by Type in 2021
Table Global Gene Therapy for CNS Disorders Revenue (Million USD) by Type (2017-2022)
Table Global Gene Therapy for CNS Disorders Revenue Market Share by Type (2017-2022)
Figure Global Gene Therapy for CNS Disorders Revenue Market Share by Type in 2021
Table Gene Therapy for CNS Disorders Price by Type (2017-2022)
Figure Global Gene Therapy for CNS Disorders Sales Volume and Growth Rate of AAV (2017-2022)
Figure Global Gene Therapy for CNS Disorders Revenue (Million USD) and Growth Rate of AAV (2017-2022)
Figure Global Gene Therapy for CNS Disorders Sales Volume and Growth Rate of Adenovirus (2017-2022)
Figure Global Gene Therapy for CNS Disorders Revenue (Million USD) and Growth Rate of Adenovirus (2017-2022)
Table Global Gene Therapy for CNS Disorders Consumption by Application (2017-2022)
Table Global Gene Therapy for CNS Disorders Consumption Market Share by Application (2017-2022)
Table Global Gene Therapy for CNS Disorders Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Gene Therapy for CNS Disorders Consumption Revenue Market Share by Application (2017-2022)
Table Global Gene Therapy for CNS Disorders Consumption and Growth Rate of SMA (2017-2022)
Table Global Gene Therapy for CNS Disorders Consumption and Growth Rate of Others (2017-2022)
Figure Global Gene Therapy for CNS Disorders Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Gene Therapy for CNS Disorders Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Gene Therapy for CNS Disorders Price and Trend Forecast (2022-2027)
Figure USA Gene Therapy for CNS Disorders Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Gene Therapy for CNS Disorders Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Gene Therapy for CNS Disorders Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Gene Therapy for CNS Disorders Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Gene Therapy for CNS Disorders Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Gene Therapy for CNS Disorders Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Gene Therapy for CNS Disorders Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Gene Therapy for CNS Disorders Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Gene Therapy for CNS Disorders Market Sales Volume Forecast, by Type
Table Global Gene Therapy for CNS Disorders Sales Volume Market Share Forecast, by Type
Table Global Gene Therapy for CNS Disorders Market Revenue (Million USD) Forecast, by Type
Table Global Gene Therapy for CNS Disorders Revenue Market Share Forecast, by Type
Table Global Gene Therapy for CNS Disorders Price Forecast, by Type
Figure Global Gene Therapy for CNS Disorders Revenue (Million USD) and Growth Rate of AAV (2022-2027)
Figure Global Gene Therapy for CNS Disorders Revenue (Million USD) and Growth Rate of AAV (2022-2027)
Figure Global Gene Therapy for CNS Disorders Revenue (Million USD) and Growth Rate of Adenovirus (2022-2027)
Figure Global Gene Therapy for CNS Disorders Revenue (Million USD) and Growth Rate of Adenovirus (2022-2027)
Table Global Gene Therapy for CNS Disorders Market Consumption Forecast, by Application
Table Global Gene Therapy for CNS Disorders Consumption Market Share Forecast, by Application
Table Global Gene Therapy for CNS Disorders Market Revenue (Million USD) Forecast, by Application
Table Global Gene Therapy for CNS Disorders Revenue Market Share Forecast, by Application
Figure Global Gene Therapy for CNS Disorders Consumption Value (Million USD) and Growth Rate of SMA (2022-2027)
Figure Global Gene Therapy for CNS Disorders Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Gene Therapy for CNS Disorders Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Roche (Spark Therapeutics) Profile
Table Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Sales Volume and Growth Rate
Figure Roche (Spark Therapeutics) Revenue (Million USD) Market Share 2017-2022
Table Voyager Therapeutics Profile
Table Voyager Therapeutics Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Voyager Therapeutics Gene Therapy for CNS Disorders Sales Volume and Growth Rate
Figure Voyager Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Novartis AG Profile
Table Novartis AG Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG Gene Therapy for CNS Disorders Sales Volume and Growth Rate
Figure Novartis AG Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Gene Therapy for CNS Disorders Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
Table Biogen Profile
Table Biogen Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biogen Gene Therapy for CNS Disorders Sales Volume and Growth Rate
Figure Biogen Revenue (Million USD) Market Share 2017-2022
Table bluebird bio, Inc. Profile
Table bluebird bio, Inc. Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure bluebird bio, Inc. Gene Therapy for CNS Disorders Sales Volume and Growth Rate
Figure bluebird bio, Inc. Revenue (Million USD) Market Share 2017-2022
Figure Gene Therapy for CNS Disorders Product Picture
Table Global Gene Therapy for CNS Disorders Market Sales Volume and CAGR (%) Comparison by Type
Table Gene Therapy for CNS Disorders Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Gene Therapy for CNS Disorders Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Gene Therapy for CNS Disorders Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Gene Therapy for CNS Disorders Industry Development
Table Global Gene Therapy for CNS Disorders Sales Volume by Player (2017-2022)
Table Global Gene Therapy for CNS Disorders Sales Volume Share by Player (2017-2022)
Figure Global Gene Therapy for CNS Disorders Sales Volume Share by Player in 2021
Table Gene Therapy for CNS Disorders Revenue (Million USD) by Player (2017-2022)
Table Gene Therapy for CNS Disorders Revenue Market Share by Player (2017-2022)
Table Gene Therapy for CNS Disorders Price by Player (2017-2022)
Table Gene Therapy for CNS Disorders Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Gene Therapy for CNS Disorders Sales Volume, Region Wise (2017-2022)
Table Global Gene Therapy for CNS Disorders Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Gene Therapy for CNS Disorders Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Gene Therapy for CNS Disorders Sales Volume Market Share, Region Wise in 2021
Table Global Gene Therapy for CNS Disorders Revenue (Million USD), Region Wise (2017-2022)
Table Global Gene Therapy for CNS Disorders Revenue Market Share, Region Wise (2017-2022)
Figure Global Gene Therapy for CNS Disorders Revenue Market Share, Region Wise (2017-2022)
Figure Global Gene Therapy for CNS Disorders Revenue Market Share, Region Wise in 2021
Table Global Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Gene Therapy for CNS Disorders Sales Volume by Type (2017-2022)
Table Global Gene Therapy for CNS Disorders Sales Volume Market Share by Type (2017-2022)
Figure Global Gene Therapy for CNS Disorders Sales Volume Market Share by Type in 2021
Table Global Gene Therapy for CNS Disorders Revenue (Million USD) by Type (2017-2022)
Table Global Gene Therapy for CNS Disorders Revenue Market Share by Type (2017-2022)
Figure Global Gene Therapy for CNS Disorders Revenue Market Share by Type in 2021
Table Gene Therapy for CNS Disorders Price by Type (2017-2022)
Figure Global Gene Therapy for CNS Disorders Sales Volume and Growth Rate of AAV (2017-2022)
Figure Global Gene Therapy for CNS Disorders Revenue (Million USD) and Growth Rate of AAV (2017-2022)
Figure Global Gene Therapy for CNS Disorders Sales Volume and Growth Rate of Adenovirus (2017-2022)
Figure Global Gene Therapy for CNS Disorders Revenue (Million USD) and Growth Rate of Adenovirus (2017-2022)
Table Global Gene Therapy for CNS Disorders Consumption by Application (2017-2022)
Table Global Gene Therapy for CNS Disorders Consumption Market Share by Application (2017-2022)
Table Global Gene Therapy for CNS Disorders Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Gene Therapy for CNS Disorders Consumption Revenue Market Share by Application (2017-2022)
Table Global Gene Therapy for CNS Disorders Consumption and Growth Rate of SMA (2017-2022)
Table Global Gene Therapy for CNS Disorders Consumption and Growth Rate of Others (2017-2022)
Figure Global Gene Therapy for CNS Disorders Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Gene Therapy for CNS Disorders Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Gene Therapy for CNS Disorders Price and Trend Forecast (2022-2027)
Figure USA Gene Therapy for CNS Disorders Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Gene Therapy for CNS Disorders Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Gene Therapy for CNS Disorders Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Gene Therapy for CNS Disorders Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Gene Therapy for CNS Disorders Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Gene Therapy for CNS Disorders Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Gene Therapy for CNS Disorders Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Gene Therapy for CNS Disorders Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Gene Therapy for CNS Disorders Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Gene Therapy for CNS Disorders Market Sales Volume Forecast, by Type
Table Global Gene Therapy for CNS Disorders Sales Volume Market Share Forecast, by Type
Table Global Gene Therapy for CNS Disorders Market Revenue (Million USD) Forecast, by Type
Table Global Gene Therapy for CNS Disorders Revenue Market Share Forecast, by Type
Table Global Gene Therapy for CNS Disorders Price Forecast, by Type
Figure Global Gene Therapy for CNS Disorders Revenue (Million USD) and Growth Rate of AAV (2022-2027)
Figure Global Gene Therapy for CNS Disorders Revenue (Million USD) and Growth Rate of AAV (2022-2027)
Figure Global Gene Therapy for CNS Disorders Revenue (Million USD) and Growth Rate of Adenovirus (2022-2027)
Figure Global Gene Therapy for CNS Disorders Revenue (Million USD) and Growth Rate of Adenovirus (2022-2027)
Table Global Gene Therapy for CNS Disorders Market Consumption Forecast, by Application
Table Global Gene Therapy for CNS Disorders Consumption Market Share Forecast, by Application
Table Global Gene Therapy for CNS Disorders Market Revenue (Million USD) Forecast, by Application
Table Global Gene Therapy for CNS Disorders Revenue Market Share Forecast, by Application
Figure Global Gene Therapy for CNS Disorders Consumption Value (Million USD) and Growth Rate of SMA (2022-2027)
Figure Global Gene Therapy for CNS Disorders Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Gene Therapy for CNS Disorders Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Roche (Spark Therapeutics) Profile
Table Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Sales Volume and Growth Rate
Figure Roche (Spark Therapeutics) Revenue (Million USD) Market Share 2017-2022
Table Voyager Therapeutics Profile
Table Voyager Therapeutics Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Voyager Therapeutics Gene Therapy for CNS Disorders Sales Volume and Growth Rate
Figure Voyager Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Novartis AG Profile
Table Novartis AG Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG Gene Therapy for CNS Disorders Sales Volume and Growth Rate
Figure Novartis AG Revenue (Million USD) Market Share 2017-2022
Table Pfizer Inc. Profile
Table Pfizer Inc. Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Inc. Gene Therapy for CNS Disorders Sales Volume and Growth Rate
Figure Pfizer Inc. Revenue (Million USD) Market Share 2017-2022
Table Biogen Profile
Table Biogen Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biogen Gene Therapy for CNS Disorders Sales Volume and Growth Rate
Figure Biogen Revenue (Million USD) Market Share 2017-2022
Table bluebird bio, Inc. Profile
Table bluebird bio, Inc. Gene Therapy for CNS Disorders Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure bluebird bio, Inc. Gene Therapy for CNS Disorders Sales Volume and Growth Rate
Figure bluebird bio, Inc. Revenue (Million USD) Market Share 2017-2022
